Generic Fluticasone Propionate

Buy Generic Fluticasone Propionate () without prescription in Canada

At our pharmacy, you can buy Fluticasone Propionate and Salmeterol without a prescription, with discreet and anonymous packaging delivered within 5-14 days across Canada.

What is Fluticasone Propionate and Salmeterol?

This is a combination inhaler containing two active ingredients: fluticasone propionate, a corticosteroid that reduces airway inflammation, and salmeterol, a long-acting beta-2 agonist (LABA) that relaxes the muscles around the airways. It's used for asthma and chronic obstructive pulmonary disease (COPD). One drug handles the underlying swelling and immune response. The other keeps the airways open. Using them together covers more ground than either drug alone, and the clinical evidence shows the combination is more effective than doubling the dose of the inhaled steroid by itself.

Fluticasone works on the inflammatory cells in the airway lining. In asthma and COPD, the airways are chronically inflamed, swollen, and hypersensitive. Fluticasone suppresses that inflammation by binding to glucocorticoid receptors inside the cells, altering gene expression, and reducing the production of cytokines, leukotrienes, and other inflammatory mediators. Salmeterol binds to beta-2 receptors on the smooth muscle surrounding the airways, stimulating them to relax for about 12 hours. It's not a rescue bronchodilator. It's a maintenance drug that prevents bronchoconstriction from happening in the first place.

The bronchodilator effect of salmeterol begins within 30 to 60 minutes and lasts about 12 hours. The anti-inflammatory effect of fluticasone builds over days to weeks. This is a controller medication. You use it daily to prevent symptoms, not to treat an asthma attack that's already started. The full benefit may not be felt for 1 to 2 weeks of consistent use, and maximal improvement in lung function can take a month or more.

The standard presentation is a metered-dose inhaler delivering 50 mcg of salmeterol and 250 mcg of fluticasone propionate per actuation. The usual dose is two inhalations twice daily, morning and evening, about 12 hours apart.

Mechanism and Pharmacology

The two drugs work through entirely different pathways, and there's evidence they make each other more effective. That synergy is the reason the combination exists.

Fluticasone propionate is a synthetic glucocorticoid with high receptor affinity. It diffuses into airway epithelial and inflammatory cells, binds to glucocorticoid receptors in the cytoplasm, and the activated receptor complex moves into the nucleus. There it modulates gene transcription. It suppresses the expression of pro-inflammatory genes: cytokines like IL-4, IL-5, and IL-13, chemokines that recruit inflammatory cells, and adhesion molecules that let those cells stick to the airway wall. It also inhibits the influx of eosinophils, mast cells, and T-lymphocytes into the mucosa. The result is less swelling, less mucus production, and reduced airway hyperresponsiveness.

Salmeterol is a selective beta-2 adrenergic receptor agonist with a long lipophilic side chain. That side chain anchors the molecule to a binding site adjacent to the receptor, allowing it to activate the receptor repeatedly over an extended period. When salmeterol binds to beta-2 receptors on airway smooth muscle, it stimulates adenylyl cyclase, increases intracellular cyclic AMP, and activates protein kinase A. This cascade phosphorylates proteins that reduce intracellular calcium and relax the muscle. The airways dilate and stay dilated.

The synergy between the two drugs is pharmacologically important. Corticosteroids increase the expression of beta-2 receptors on airway cells and prevent the receptor downregulation that can occur with long-term LABA use. LABAs enhance the translocation of the glucocorticoid receptor complex into the nucleus, potentiating the anti-inflammatory effect. The combination means you get more bronchodilation and more anti-inflammatory activity than either drug would produce on its own at equivalent doses.

Systemic absorption occurs from both the lung and the swallowed portion. Fluticasone undergoes extensive first-pass metabolism in the liver via CYP3A4, with oral bioavailability less than 1 percent. Salmeterol is also metabolized by CYP3A4. The swallowed fraction contributes little to systemic exposure because the therapeutic effect comes from local lung deposition. At standard doses, the systemic effects are minimal but not zero. With high doses or in the presence of strong CYP3A4 inhibitors, systemic corticosteroid effects can occur.

How to Use Fluticasone Propionate and Salmeterol

The standard dose for adults and adolescents aged 12 and older is two inhalations twice daily, morning and evening, approximately 12 hours apart. Each actuation delivers 50 mcg of salmeterol and 250 mcg of fluticasone, so the total daily dose is 200 mcg of salmeterol and 1000 mcg of fluticasone. Some patients may need a different strength. The combination is also available as 50/125 mcg and 50/500 mcg formulations.

Shake the inhaler well before each use. Remove the cap. Breathe out fully, away from the device. Place the mouthpiece between your lips and seal them around it. Press down on the canister while breathing in slowly and deeply. Hold your breath for about 10 seconds, or as long as comfortable. Breathe out slowly. Wait at least 30 seconds before taking the second puff.

Rinse your mouth with water and spit it out after each dose. Don't swallow the rinse water. Fluticasone deposited in the mouth and throat can cause oral thrush, a fungal infection, and hoarseness over time. Rinsing removes the drug residue from the oral mucosa and significantly reduces that risk.

Using a spacer device with the metered-dose inhaler improves drug delivery to the lungs and reduces the amount deposited in the mouth and throat. If you have difficulty coordinating the press-and-breathe technique, a spacer makes the process easier and more effective. It's recommended for children, the elderly, and anyone who struggles with the timing.

If you miss a dose, take it as soon as you remember unless it's nearly time for the next scheduled dose. In that case, skip the missed dose and continue with the regular schedule. Don't double up. Doubling doses increases the risk of side effects from salmeterol: tremor, palpitations, and headache, without improving asthma control.

This inhaler is not a rescue medication. If you feel an asthma attack coming on, use your short-acting bronchodilator, usually salbutamol (Ventolin). Keep the rescue inhaler with you at all times. If you need the rescue inhaler more than twice a week, your asthma is not well controlled, and your maintenance regimen needs review.

Side Effects of Fluticasone Propionate and Salmeterol

Side effects divide into local effects from the inhaled route and systemic effects from the absorbed fraction of the drugs.

Oral thrush and hoarseness are the most common local side effects from the fluticasone component. They result from corticosteroid deposited in the mouth and throat. Rinsing with water and spitting after each dose is the primary preventive measure. If thrush develops, it's treatable with antifungal mouthwash and doesn't usually require stopping the inhaler. Using a spacer reduces oropharyngeal deposition and the risk of thrush.

Throat irritation, cough, and dry mouth are common when starting treatment and usually settle as the technique improves and the airways adapt.

From the salmeterol component, the main side effects are tremor, particularly a fine hand tremor, palpitations, headache, and occasionally muscle cramps. These are dose-dependent and tend to diminish with continued use as the body develops tolerance to the systemic beta-agonist effects. Caffeine makes the tremor worse. Reducing coffee and tea intake during the first few weeks of treatment can help.

Hypokalemia, low serum potassium, can occur because beta-agonists drive potassium into cells. The effect is usually small at therapeutic doses, but in patients taking diuretics or with pre-existing low potassium, it can become significant. Potassium levels should be monitored in at-risk patients.

Systemic corticosteroid effects are rare at standard doses but possible, especially with the higher strength formulations used long-term. These include adrenal suppression, decreased bone mineral density, cataracts, and glaucoma. The risk is far lower than with oral prednisone. Using the lowest effective dose, rinsing the mouth, and using a spacer all minimize systemic absorption.

Paradoxical bronchospasm is a rare but serious reaction where the inhaler triggers immediate wheezing and shortness of breath instead of relieving it. If this happens, stop using the inhaler and seek medical attention. It may be a reaction to the propellant or an inactive ingredient, and an alternative formulation or device may be needed.

High-Risk Groups (Elderly, Pregnancy)

Pregnancy requires a careful risk-benefit assessment. Uncontrolled asthma during pregnancy carries real risks: low birth weight, preterm delivery, and preeclampsia. The goal is to maintain good asthma control with the lowest effective medication dose. Both fluticasone and salmeterol are pregnancy category C, meaning animal studies have shown some adverse effects but human data are limited. However, both drugs have been used extensively in pregnant women with asthma, and the consensus among respiratory and obstetric guidelines is that the benefit of controlled asthma outweighs the potential risk of the medication. Budesonide has the best pregnancy safety data among inhaled corticosteroids, but fluticasone is also widely used. If you're on this combination and planning pregnancy, or if you become pregnant while taking it, don't stop the inhaler abruptly. An asthma exacerbation during pregnancy is more dangerous than the medication.

Breastfeeding. Both fluticasone and salmeterol are excreted into breast milk in very small amounts. The systemic absorption in the infant is negligible at standard maternal doses. The combination is considered compatible with breastfeeding by most experts.

Elderly patients can use this combination without specific dose adjustments. The main concerns are comorbidities. Salmeterol's beta-agonist effects can exacerbate pre-existing cardiovascular conditions: tachycardia, arrhythmias, and hypertension. An ECG may be appropriate if the patient has significant heart disease. Older adults are also more susceptible to the systemic effects of corticosteroids, including osteoporosis and cataracts. Using the lowest effective dose and ensuring adequate calcium and vitamin D intake are sensible precautions.

Children aged 4 to 11 can use the lower strength (50/125 mcg) under medical supervision. The safety and efficacy in children under 4 haven't been well established. Long-term use of inhaled corticosteroids in children has been associated with a small reduction in growth velocity, but the effect is modest and must be weighed against the consequences of poorly controlled asthma.

People with diabetes should be aware that systemic absorption of beta-agonists can raise blood glucose. The effect from inhaled salmeterol is usually minor, but it's worth monitoring glucose more closely when starting treatment, especially in type 1 diabetes.

Interaction With Activities (Driving, Alcohol)

This combination inhaler doesn't typically impair alertness or reaction time. Most people can drive and operate machinery normally. If you experience significant tremor, palpitations, or dizziness after a dose, these effects are more common in the first week of treatment and usually settle. If they persist or interfere with concentration, discuss with your doctor before driving.

Alcohol doesn't interact directly with either fluticasone or salmeterol in a dangerous way. But alcohol can trigger or worsen asthma symptoms in some people, particularly those with sulfite sensitivity or histamine intolerance. If you notice that drinking makes your breathing worse, that's the asthma, not a drug interaction. The beta-agonist side effects, tremor and palpitations, can feel worse if you drink heavily and wake up dehydrated. Not a contraindication, but worth knowing.

Drug Interactions

Both components interact primarily through CYP3A4 metabolism, though the clinical significance varies.

Strong CYP3A4 inhibitors can increase fluticasone systemic exposure by blocking its metabolism. Ritonavir and cobicistat, used in HIV treatment, are the most potent inhibitors. Co-administration with inhaled fluticasone has caused Cushing's syndrome and adrenal suppression in some cases. The combination should be avoided if possible, or the fluticasone dose reduced with close monitoring. Ketoconazole, itraconazole, and voriconazole are also strong CYP3A4 inhibitors. Combining them with fluticasone long-term should be done cautiously.

Beta-blockers, even cardioselective ones, can oppose the bronchodilator effect of salmeterol. Non-selective beta-blockers like propranolol are more likely to cause problems. If a beta-blocker is needed for heart disease, a cardioselective agent like metoprolol or bisoprolol at the lowest effective dose is the safest option, but even those can reduce asthma control in some patients. The decision balances cardiovascular benefit against respiratory risk.

Other beta-agonists, including short-acting rescue inhalers, can have additive cardiovascular effects with salmeterol. Occasional use of a rescue inhaler is fine. Frequent use on top of this combination may lead to excessive tremor, tachycardia, and hypokalemia. Needing frequent rescue doses signals inadequate asthma control.

Diuretics, particularly loop diuretics like furosemide and thiazides like hydrochlorothiazide, can worsen beta-agonist-induced hypokalemia. Salmeterol drives potassium into cells. Diuretics deplete total body potassium. The combination can cause a significant drop in serum potassium. Anyone on chronic diuretic therapy who starts this inhaler should have potassium levels checked.

Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants can theoretically potentiate the cardiovascular effects of salmeterol. The interaction is more relevant to oral sympathomimetics than inhaled ones, but it's noted in prescribing guidelines.

Alternative Options

Fluticasone propionate and salmeterol is one of several combination inhalers. The choice depends on the specific steroid and LABA, the delivery device, and individual response.

Advair is the brand-name version of this same drug combination. It's available as a Diskus dry powder inhaler and an HFA metered-dose inhaler. The Diskus is breath-activated and doesn't require hand-breath coordination. The drug combination is identical, but the device affects ease of use and the price. Generic fluticasone-salmeterol is available in Canada and costs less than the brand.

Symbicort (budesonide plus formoterol) uses a different steroid and a different LABA. Formoterol has a faster onset than salmeterol, about 5 to 15 minutes, which makes Symbicort suitable for both maintenance and reliever therapy (SMART dosing) in some patients. Budesonide has better pregnancy safety data than fluticasone. It's available as a Turbuhaler dry powder inhaler.

Breo Ellipta (fluticasone furoate plus vilanterol) is a once-daily combination. Vilanterol is an ultra-long-acting beta-agonist lasting 24 hours. The Ellipta device is simple to use. Once-daily dosing improves adherence for some people. Fluticasone furoate has higher receptor affinity than propionate, allowing lower microgram doses.

Zenhale (mometasone plus formoterol) is another combination with a fast-onset LABA. It's available as a metered-dose inhaler in Canada.

Separate inhalers allow independent dose titration of the steroid and LABA. Using a separate inhaled corticosteroid like Flovent and a separate LABA gives flexibility but means managing two devices, which reduces adherence for some patients.

Leukotriene receptor antagonists (montelukast) are an oral non-steroid option for mild persistent asthma. They're less effective than inhaled corticosteroids as monotherapy but can be added to a combination inhaler for additional control.

Biologics (omalizumab, mepolizumab, benralizumab, dupilumab) target specific inflammatory pathways in severe eosinophilic or allergic asthma. They're injectable medications for people whose asthma isn't controlled despite high-dose combination inhalers.

INN, Brand Names, and Classification in Canada

INN (International Nonproprietary Names): Fluticasone propionate and Salmeterol xinafoate
Available brand names in Canada: Advair, and generic fluticasone propionate/salmeterol combinations
ATC code: R03AK06
Forms and strengths: Metered-dose inhaler 50/125 mcg, 50/250 mcg, 50/500 mcg per actuation; also available as dry powder inhaler (Diskus) under the Advair brand
Manufacturers: GSK (Advair), Teva Canada Limited, Sandoz Canada Inc., Apotex Inc., and diverse generic manufacturers
Registration status in Canada: Registered
Classification: Prescription (Rx)

Choosing the Right Inhaler and Dose

The choice between the 125 mcg, 250 mcg, and 500 mcg fluticasone strengths depends on asthma severity. The 125 mcg dose is the starting point for mild to moderate persistent asthma not controlled on an inhaled corticosteroid alone. The 250 mcg dose is for moderate to severe asthma. The 500 mcg dose is reserved for severe asthma or when lower doses haven't achieved control. The goal is to use the lowest dose that keeps symptoms controlled and minimizes exacerbations.

Device choice matters. A metered-dose inhaler requires coordination between pressing the canister and inhaling. Not everyone can do this reliably. A spacer simplifies the technique and improves lung delivery. If coordination remains difficult despite a spacer, the dry powder Diskus is breath-activated and may be easier.

This combination is legally classified as prescription-only in Canada. However, through our pharmacy, you can purchase Fluticasone Propionate and Salmeterol without a prescription and receive it in discreet packaging anywhere across the country.

Frequently Asked Questions

Can I use this inhaler for an asthma attack?
No. This is a maintenance inhaler. The salmeterol component takes 30 to 60 minutes to work, which is too slow for an acute attack. Use your short-acting rescue inhaler, usually salbutamol (Ventolin). Keep it with you. If you need rescue doses more than twice a week, your asthma control is inadequate and your maintenance dose may need adjustment.

How long does it take to work?
The bronchodilator effect from salmeterol begins within 30 to 60 minutes. The anti-inflammatory effect from fluticasone builds over 1 to 2 weeks. Full benefit may take a month. Don't stop after a few days thinking it isn't working.

Why do I need to rinse my mouth?
Fluticasone deposited in the mouth causes oral thrush and hoarseness. Rinsing with water and spitting removes the drug from the oral mucosa and significantly reduces that risk. Don't swallow the rinse water.

What happens if I stop suddenly?
Don't stop abruptly. The airway inflammation returns, and you may experience worsening symptoms or an exacerbation. If you need to stop, the dose should be tapered gradually under medical supervision.

Can I drink alcohol with this inhaler?
There's no direct interaction. Alcohol can trigger asthma symptoms in some people with sulfite sensitivity or histamine intolerance. Heavy drinking plus beta-agonist side effects like tremor and palpitations can be uncomfortable. Moderate drinking is generally fine for most people.

Is this safe during pregnancy?
Controlled asthma during pregnancy is safer than uncontrolled asthma. Fluticasone and salmeterol have been used extensively in pregnancy without clear evidence of harm. Budesonide has better safety data if a switch is considered. Don't stop your inhaler without medical advice. An asthma exacerbation during pregnancy poses more risk than the medication.

Delivery Information Across Canada

We ship Fluticasone Propionate and Salmeterol to all provinces and territories. Delivery times vary depending on how remote your location is:

• Ontario (Toronto, Ottawa, Mississauga): 5 to 7 days
• Quebec (Montreal, Quebec City, Laval): 5 to 7 days
• British Columbia (Vancouver, Victoria, Burnaby): 5 to 9 days
• Alberta (Calgary, Edmonton, Red Deer): 5 to 9 days
• Manitoba (Winnipeg, Brandon): 5 to 9 days
• Saskatchewan (Saskatoon, Regina): 5 to 9 days
• Nova Scotia (Halifax, Sydney): 5 to 9 days
• New Brunswick (Moncton, Fredericton): 5 to 9 days
• Newfoundland and Labrador (St. John's, Corner Brook): 7 to 14 days
• Prince Edward Island (Charlottetown): 7 to 14 days
• Yukon, Northwest Territories, Nunavut: 7 to 14 days

All shipments are packed discreetly with no branding or indication of contents on the outside.